MATTHEW MORGAN: Open Payments
NPI 1457322943 · NORTHGLENN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,099 in 172 payments from 21 companies in 2025. Trend: 2023 $3,256 · 2024 $2,786 · 2025 $3,099
Food & beverage: $3,099
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $577 |
| AstraZeneca Pharmaceuticals LP | 23 | $499 |
| GlaxoSmithKline, LLC. | 16 | $285 |
| PFIZER INC. | 12 | $214 |
| Amgen Inc. | 20 | $193 |
| Janssen Pharmaceuticals, Inc | 4 | $178 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $149 |
| Lilly USA, LLC | 10 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $130 |
Products named: VRAYLAR, SPRAVATO, TRELEGY ELLIPTA, NURTEC ODT, Kerendia, JARDIANCE, CAPLYTA, MOUNJARO.
Industry payments across CO — which companies pay providers there.
